Many investigators have reported proliferation of terminal cutaneous n
erves and upregulation of various neuropeptides (substance P, vasoacti
ve intestinal polypeptide, calcitonin gene-related peptide) in psoriat
ic lesions. Nerve growth factor promotes growth of nerves and causes u
pregulation of neuropeptides Like substance P and calcitonin gene-rela
ted peptide. In this study we investigated the expression of nerve gro
wth factor in psoriatic lesions, non-lesional psoriatic skin, lichen p
lanus and normal control skin. Immunoperoxidase staining was applied o
n cryosections prepared from snap-frozen biopsy specimens. The primary
antibody used was a polyclonal anti-NGF-beta antibody. Nerve growth f
actor was detected only in the keratinocytes. In psoriatic tissue the
number of keratinocytes per square millimeter of epidermis positive fo
r nerve growth factor was 84.7 +/- 46.3 compared to 44.8 +/- 29.9, 18.
9 +/- 11.8 and 7.5 +/- 16.9, respectively, in non-lesional psoriatic s
kin, normal skin and lichen planus. Increased expression of nerve grow
th factor substantiates larger numbers of terminal cutaneous nerves an
d upregulations of substance P and calcitonin gene-related peptide in
psoriatic lesions. In addition, nerve growth factor is mitogenic to ke
ratinocytes, activates T-lymphocytes and can induce migration of infla
mmatory cellular infiltrates, histological features characteristic of
psoriasis.